Structural blueprint of nanoparticles developed to target neutrophils responsible for acute lung inflammation

By | December 28, 2021
The COVID-19 pandemic highlighted the devastating impact of acute lung inflammation (ALI), which is part of the acute respiratory distress syndrome (ARDS) that is the dominant cause of death in COVID-19.